the effect of tofacitinib on bone mineral density in patients with rheumatoid arthritis
Phase 4
- Conditions
- to determine the effect of tofacitinib on bone
- Registration Number
- JPRN-UMIN000027242
- Lead Sponsor
- Division of rheumatology, hiroshima clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
patients had received steroids, bisphosphonates, or parathyroid hormone.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the comparison of the BMD of the lumbar spine and femoral neck at baseline and 52 weeks after tofacitinib treatment.
- Secondary Outcome Measures
Name Time Method the comparison of the bone marker at baseline and 52 weeks after tofacitinib treatment